Both in Lab Analytical Instruments
Harvard Bioscience vs Seer
Over the past year HBIO returned +72.3% and SEER returned −24.0%; their daily moves had a correlation of 0.01.
HBIO +72.3% SEER −24.0%Growth of $1, one year, split-adjusted
| Metric | HBIO | SEER |
|---|---|---|
| Price | $8.90 | $1.68 |
| Market cap | $40.5M | $93.0M |
| Today | +1.14% | −13.40% |
| 1 month | +9.5% | −23.6% |
| 6 months | +39.9% | −17.2% |
| Year to date | +33.1% | −8.2% |
| 1 year | +99.3% | −24.3% |
| Revenue growth (YoY) | +11.1% | −23.4% |
| Gross margin | 55.6% | 48.5% |
| Net margin | −12.8% | −544.8% |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | 6.5× |
| Net cash | -$30.2M | $152.9M |
| Dividend yield | — | — |
| Volatility (60d) | 36.4% | 44.3% |
| Short % of float | 1.5% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).